You are here:


All publications

427. Casares-Magaz O, Muren LP, Moiseenko V, Petersen SE, Pettersson NJ, Høyer M, Deasy JO, Thor M. Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer. Acta Oncol. 2017 Sep 8:1-7.

426. Kaplan LP, Høye EM, Balling P, Muren LP, Petersen JBB, Poulsen PR, Yates ES, Skyt PS. Determining the mechanical properties of a radiochromic silicone-based 3D dosimeter. Phys Med Biol. 2017 Jun 14;62(14):5612-5622.

425. Johansen JG, Rylander S, Buus S, Bentzen L, Hokland SB, Søndergaard CS, With AKM, Kertzscher G, Tanderup K. Time-resolved in vivo dosimetry for source tracking in brachytherapy. Brachytherapy. 2017 Sep 21

424. Buus S, Lizondo M, Hokland S, Rylander S, Pedersen EM, Tanderup K, Bentzen L. Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI. Brachytherapy. 2017 Sep 18.

423. Lindegaard JC, Assenholt M, Ramlov A, Fokdal LU, Alber M, Tanderup K. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer. Acta Oncol. 2017 Aug 29:1-8.

421. Zukauskaite R, Hansen CR, Brink C, Johansen J, Asmussen JT, Grau C, Overgaard J, Eriksen JG. Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods. Acta Oncol. 2017 Aug 22:1-8.

420. Sørensen BS, Bassler N, Nielsen S, Horsman MR, Grzanka L, Spejlborg H, Swakoń J, Olko P, Overgaard J. Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo. Acta Oncol. 2017 Aug 23:1-5.

419. Schack LMH, Petersen SE, Nielsen S, Lundby L, Høyer M, Bentzen L, Overgaard J, Andreassen CN, Alsner J. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients. Acta Oncol. 2017 Aug 26:1-8.

418. Nielsen S, Bassler N, Grzanka L, Swakon J, Olko P, Andreassen CN, Overgaard J, Alsner J, Sørensen BS. Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiation. Acta Oncol. 2017 Sep 8:1-7.

416. Hansen O, Knap MM, Khalil A, Nyhus CH, McCulloch T, Holm B, Brink C, Hoffmann L, Schytte T. A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC. Radiother Oncol. 2017 Apr 11.

414. Holm AIS, Petersen JBB, Muren LP, Seiersen K, Borghammer P, Lukacova S. Functional image-guided dose escalation in gliomas using of state-of-the-art photon vs. proton therapy. Acta Oncol. 2017 Jun;56(6):826-831.

413. Busch K, G Andersen A, Casares-Magaz O, Petersen JBB, Bentzen L, Thörnqvist S, Muren LP. Evaluating the influence of organ motion during photon vs. proton therapy for locally advanced prostate cancer using biological models. Acta Oncol. 2017 Jun;56(6):839-845.

412. Gravgaard Andersen A, Casares-Magaz O, Petersen J, Toftegaard J, Bentzen L, Thörnqvist S, Muren LP. Beam angle evaluation to improve inter-fraction motion robustness in pelvic lymph node irradiation with proton therapy. Acta Oncol. 2017 Jun;56(6):846-852.

411. Ramlov A, Pedersen EM, Røhl L, Worm E, Fokdal L, Lindegaard JC, Tanderup K. Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1032-1039.

410. Rylander S, Buus S, Pedersen EM, Bentzen L, Tanderup K. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning. Radiother Oncol. 2017 Apr;123(1):125-132

409. Toftegaard J, Hansen R, Ravkilde T, Macek K, Poulsen PR. An experimentally validated couch and MLC tracking simulator used to investigate hybrid couch-MLC tracking. Med Phys. 2017 Jan 12.

408. Ramlov A, Assenholt MS, Jensen MF, Grønborg C, Nout R, Alber M, Fokdal L, Tanderup K, Lindegaard JC. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiother Oncol. 2017 Feb 9.

407. Høye EM, Skyt PS, Balling P, Muren LP, Taasti VT, Swakoń J, Mierzwińska G, Rydygier M, Bassler N, Petersen JB. Chemically tuned linear energy transfer dependent quenching in a deformable, radiochromic 3D dosimeter. Phys Med Biol. 2017 Feb 21;62(4):N73-N89.

406. Bertholet J, Wan H, Toftegaard J, Schmidt ML, Chotard F, Parikh PJ, Poulsen PR. Fully automatic segmentation of arbitrarily shaped fiducial markers in cone-beam CT projections. Phys Med Biol. 2017 Feb 21;62(4):1327-1341.

405. Busk M, Munk OL, Jakobsen S, Frøkiær J, Overgaard J, Horsman MR. FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach. Acta Oncol. 2017 May;56(5):706-712.

404. Murtaza G, Toftegaard J, Khan EU, Poulsen PR. Volumetric modulated arc therapy with dynamic collimator rotation for improved multileaf collimator tracking of the prostate. Radiother Oncol. 2017 Jan;122(1):109-115.

403. Ipsen S, Bruder R, O'Brien R, Keall PJ, Schweikard A, Poulsen PR. Online 4D ultrasound guidance for real-time motion compensation by MLC tracking. Med Phys. 2016 Oct;43(10):5695.

402. Hvid CA, Elstrøm UV, Jensen K, Alber M, Grau C. Accuracy of software-assisted contour propagation from planning CT to cone beam CT in head and neck radiotherapy. Acta Oncol. 2016 Nov;55(11):1324-1330.

401. Laurberg T, Alsner J, Tramm T, Jensen V, Lyngholm CD, Christiansen PM, Overgaard J. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients. Acta Oncol. 2017 Jan;56(1):59-67.

400. Bert C, Kellermeier M, Tanderup K. Electromagnetic tracking for treatment verification in interstitial brachytherapy. J Contemp Brachytherapy. 2016 Oct;8(5):448-453.

399. Taasti VT, Høye EM, Hansen DC, Muren LP, Thygesen J, Skyt PS, Balling P, Bassler N, Grau C, Mierzwińska G, Rydygier M, Swakoń J, Olko P, Petersen JB. Technical Note: Improving proton stopping power ratio determination for a deformable silicone-based 3D dosimeter using dual energy CT. Med Phys. 2016 Jun;43(6):2780.

398. Stokkevåg CH, Fukahori M, Nomiya T, Matsufuji N, Engeseth GM, Hysing LB, Ytre-Hauge KS, Rørvik E, Szostak A, Muren LP. Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy. Radiother Oncol. 2016 Aug;120(2):300-6.

397. Taasti VT, Petersen JB, Muren LP, Thygesen J, Hansen DC. A robust empirical parametrization of proton stopping power using dual energy CT. Med Phys. 2016 Oct;43(10):5547.

396. Bertholet J, Worm ES, Fledelius W, Høyer M, Poulsen PR. Time-Resolved Intrafraction Target Translations and Rotations During Stereotactic Liver Radiation Therapy: Implications for Marker-based Localization Accuracy. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):802-9.

395. Schmidt ML, Hoffmann L, Knap MM, Rasmussen TR, Folkersen BH, Toftegaard J, Møller DS, Poulsen PR. Cardiac and respiration induced motion of mediastinal lymph node targets in lung cancer patients throughout the radiotherapy treatment course. Radiother Oncol. 2016 Oct;121(1):52-58

394. Worm ES, Bertholet J, Høyer M, Fledelius W, Hansen AT, Larsen LP, Nielsen JE, Poulsen PR. Fiducial marker guided stereotactic liver radiotherapy: Is a time delay between marker implantation and planning CT needed? Radiother Oncol. 2016 Oct;121(1):75-78.

393. Toustrup K, Sørensen BS, Metwally MA, Tramm T, Mortensen LS, Overgaard J, Alsner J. Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials. Acta Oncol. 2016 Sep-Oct;55(9-10):1091-1098.

392. Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CM, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J; International Radiogenomics Consortium (RgC). Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol. 2016 Jul 18.

391. Tanderup K, Fokdal LU, Sturdza A, Haie-Meder C, Mazeron R, van Limbergen E, Jürgenliemk-Schulz I, Petric P, Hoskin P, Dörr W, Bentzen SM, Kirisits C, Lindegaard JC, Pötter R. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016 Sep;120(3):441-446.

390. Tanderup K, Lindegaard JC, Kirisits C, Haie-Meder C, Kirchheiner K, de Leeuw A, Jürgenliemk-Schulz I, Van Limbergen E, Pötter R. Image Guided Adaptive Brachytherapy in cervix cancer: A new paradigm changing clinical practice and outcome. Radiother Oncol. 2016 Sep;120(3):365-369.

389. Hansen R, Ravkilde T, Worm ES, Toftegaard J, Grau C, Macek K, Poulsen PR. Electromagnetic guided couch and multileaf collimator tracking on a TrueBeam accelerator. Med Phys. 2016 May;43(5):2387.

388. Casares-Magaz O, van der Heide UA, Rørvik J, Steenbergen P, Muren LP. A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps. Radiother Oncol. 2016 Apr;119(1):111-6.

387. Taasti VT, Høye EM, Hansen DC, Muren LP, Thygesen J, Skyt PS, Balling P, Bassler N, Grau C, Mierzwińska G, Rydygier M, Swakoń J, Olko P, Petersen JB. Technical Note: Improving proton stopping power ratio determination for a deformable silicone-based 3D dosimeter using dual energy CT. Med Phys. 2016 Jun;43(6):2780.

386. Stokkevåg CH, Fukahori M, Nomiya T, Matsufuji N, Engeseth GM, Hysing LB, Ytre-Hauge KS, Rørvik E, Szostak A, Muren LP. Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy. Radiother Oncol. 2016 Aug;120(2):300-6.

385. Lyngholm CD, Laurberg T, Alsner J, Damsgaard TE, Overgaard J, Christiansen PM. Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort. Acta Oncol. 2016 Aug;55(8):983-92.

384. Thorsen LB, Offersen BV, Danø H, Berg M, Jensen I, Pedersen AN, Zimmermann SJ, Brodersen HJ, Overgaard M, Overgaard J. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2016 Feb 1;34(4):314-20.

383. Sørensen BS, Knudsen A, Wittrup CF, Nielsen S, Aggerholm-Pedersen N, Busk M, Horsman M, Høyer M, Bouchelouche PN, Overgaard J, Alsner J. The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types. Radiother Oncol. 2015 Sep;116(3):346-51.

381. Sørensen BS, Horsman MR, Alsner J, Overgaard J, Durante M, Scholz M, Friedrich T, Bassler N. Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model. Acta Oncol. 2015;54(9):1623-30.

380. Sørensen BS, Busk M, Overgaard J, Horsman MR, Alsner J. Simultaneous Hypoxia and Low Extracellular pH Suppress Overall Metabolic Rate and Protein Synthesis In Vitro. PLoS One. 2015 Aug 14;10(8):e0134955.

379. Winther M, Alsner J, Tramm T, Baeksgaard L, Holtved E, Nordsmark M. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer. Acta Oncol. 2015;54(9):1582-91.

378. Winther M, Alsner J, Tramm T, Holtved E, Baeksgaard L, Nordsmark M. Prognostic value of hypoxia-regulated gene expression in loco-regional gastroesophageal cancer. Acta Oncol. 2016 May;55(5):652-5.

377. Andreassen CN, Schack LM, Laursen LV, Alsner J. Radiogenomics - current status, challenges and future directions. Cancer Lett. 2016 Nov 1;382(1):127-136.

376. Winther M, Alsner J, Sørensen BS, Wittrup CF, Tramm T, Baeksgaard L, Hofland K, Holtved E, Nordsmark M. Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer. Anticancer Res. 2016 Feb;36(2):721-30.

375. Winther M, Knudsen S, Dahlgaard J, Jensen T, Hansen A, Jensen PB, Tramm T, Alsner J, Nordsmark M. Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer. PLoS One. 2016 Feb 17;11(2):e0148070.

374. Lyhne NM, Johansen J, Kristensen CA, Andersen E, Primdahl H, Andersen LJ, Bøje CR, Jensen AR, Overgaard J. Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group. Radiother Oncol. 2016 Feb;118(2):257-66.

373. Lyhne NM, Johansen J, Kristensen CA, Andersen E, Primdahl H, Andersen LJ, Oksbjerg S, Overgaard J. Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group. Eur J Cancer. 2016 Mar 22;59:46-56.

372. Pagh A, Grau C, Overgaard J. Failure pattern and salvage treatment after radical treatment of head and neck cancer. Acta Oncol. 2016 May;55(5):625-32.

371. Eriksen JG, Salembier C, Rivera S, De Bari B, Berger D, Mantello G et al. Four years with FALCON - an ESTRO educational project: achievements and perspectives. Radiother Oncol. 2014 Jul;112(1):145-9.

370. Dunscombe P, Grau C, Defourny N, Malicki J, Borras JM, Coffey M, Bogusz M et al Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey. Radiother Oncol. 2014 Aug;112(2):165-77.

369. Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Loft A, Kristensen CA, Specht L. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014 Jun;111(3):360-5.

368. Fledelius W, Worm E, Høyer M, Grau C, Poulsen PR. Real-time segmentation of multiple implanted cylindrical liver markers in kilovoltage and megavoltage x-ray images. Phys Med Biol. 2014 Jun 7;59(11):2787-800.

367. Sun B, Yang D, Esthappan J, Garcia-Ramirez J, Price S, Mutic S, Schwarz JK, Grigsby PW2, Tanderup K. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer. Brachytherapy. 2015 May 6

366. Hassan Metwally MA, Ali R, Kuddu M, Shouman T, Strojan P, Iqbal K, Prasad R, Grau C, Overgaard J. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiother Oncol. 2015 Jul;116(1):15-20.

365. Hansen DC, Petersen JB, Bassler N, Sørensen TS. Improved proton computed tomography by dual modality image reconstruction. Med Phys. 2014 Mar;41(3):031904.

364. Pagh A, Grau C, Overgaard J. A longitudinal study of follow-up activities after curative treatment for head and neck cancer. Acta Oncol. 2015 May;54(5):813-9.

363. Sander L, Langkilde NC, Holmberg M, Carl J. MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol. 2014 Jun;53(6):809-14.

362. Ravn S, Holmberg M, Sørensen P, Frokjaer JB, Carl J. Presurgical functional magnetic resonance imaging in patients with brain tumors. Acta Radiol. 2016 Jan;57(1):82-9.

359. Leth T, von Oettingen G, Lassen-Ramshad YA, Lukacova S, Høyer M. Survival and prognostic factors in patients treated with stereotactic radiotherapy for brain metastases. Acta Oncol. 2015 Jan;54(1):107-14.

358. Schmidt ML, Poulsen PR, Toftegaard J, Hoffmann L, Hansen D, Sørensen TS. Clinical use of iterative 4D-cone beam computed tomography reconstructions to investigate respiratory tumor motion in lung cancer patients. Acta Oncol. 2014 Aug;53(8):1107-13.

357. Poulsen PR, Worm ES, Petersen JB, Grau C, Fledelius W, Høyer M. Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liver. Radiother Oncol. 2014 Jun;111(3):424-30.

356. Ravkilde T, Keall PJ, Grau C, Høyer M, Poulsen PR. Fast motion-including dose error reconstruction for VMAT with and without MLC tracking. Phys Med Biol. 2014 Dec 7;59(23):7279-96.

355. Toftegaard J, Fledelius W, Seghers D, Huber M, Brehm M, Worm ES, Elstrøm UV, Poulsen PR. Moving metal artifact reduction in cone-beam CT scans with implanted cylindrical gold markers. Med Phys. 2014 Dec;41(12):121710.

354. Thor M, Andersen ES, Petersen JB, Sørensen TS, Noe KØ, Tanderup K, Bentzen L, Elstrøm UV, Høyer M, Muren LP. Evaluation of an application for intensity-based deformable image registration and dose accumulation in radiotherapy. Acta Oncol. 2014 Oct;53(10):1329-36.

353. Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JB, Elstrøm UV, Agerbæk M, Høyer M. Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer. Acta Oncol. 2014 Aug;53(8):997-1004.

352. Casares-Magaz O, Toftegaard J, Muren LP, Kallehauge JF, Bassler N, Poulsen PR, Petersen JB. A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer. Acta Oncol. 2014 Aug;53(8):1058-63.

351. Elstrøm UV, Olsen SR, Muren LP, Petersen JB, Grau C. The impact of CBCT reconstruction and calibration for radiotherapy planning in the head and neck region - a phantom study. Acta Oncol. 2014 Aug;53(8):1114-24.

350. Søndergaard J, Holmberg M, Jakobsen AR, Agerbæk M, Muren LP, Høyer M. A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer. Acta Oncol. 2014 Oct;53(10):1321-8.

349. Stokkevåg CH, Engeseth GM, Ytre-Hauge KS, Röhrich D, Odland OH, Muren LP, Brydøy M, Hysing LB, Szostak A, Palmer MB, Petersen JB. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncol. 2014 Aug;53(8):1048-57.

348. Muren LP, Teräs M, Knuuti J. NACP 2014 and the Turku PET symposium: the interaction between therapy and imaging. Acta Oncol. 2014 Aug;53(8):993-6.

347. Vestergaard A, Kallehauge JF, Petersen JB, Høyer M, Søndergaard J, Muren LP. An adaptive radiotherapy planning strategy for bladder cancer using deformation vector fields. Radiother Oncol. 2014 Sep;112(3):371-5.

346. Schytte T, Nielsen TB, Brink C, Hansen O. Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer. Acta Oncol. 2014 Mar;53(3):336-41.

345. Brink C, Bernchou U, Bertelsen A, Hansen O, Schytte T, Bentzen SM. Locoregional control of non-small cell lung cancer in relation to automated early assessment of tumor regression on cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):916-23.

344. Lorenzen EL, Ewertz M, Brink C. Automatic segmentation of the heart in radiotherapy for breast cancer. Acta Oncol. 2014 Oct;53(10):1366-72.

343. Hansen CR, Bertelsen A, Riis HL, Christiansen RL, Hansen O, Sykes JB, Thwaites DI, Brink C. Plan quality and delivery accuracy of flattening filter free beam for SBRT lung treatments. Acta Oncol. 2015 Mar;54(3):422-7.

342. Hansen O, Schytte T, Nielsen M, Brink C. Age dependent prognosis in concurrent chemo-radiation of locally advanced NSCLC. Acta Oncol. 2015 Mar;54(3):333-9.

341. Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Büttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Lühr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M. Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets. Radiother Oncol. 2014 Dec;113(3):303-9.

339. Baumann M, Overgaard J. What next? Radiother Oncol. 2014 Jan;110(1):1-2.

337. Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Børresen-Dale AL, Sørlie T, Frigessi A, Overgaard J. Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort. Clin Cancer Res. 2014 Oct 15;20(20):5272-80.

336. Sørensen BS, Busk M, Horsman MR, Alsner J, Overgaard J, Kyle AH, Minchinton AI. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models. Anticancer Res. 2014 Nov;34(11):6297-304.

335. Overgaard J. Radiotherapy. Gazing at the crystal ball of European radiotherapy. Nat Rev Clin Oncol. 2015 Jan;12(1):5-6.

334. Hassan Metwally MA, Jansen JA, Overgaard J. Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial. Clin Oncol (R Coll Radiol). 2015 Mar;27(3):168-75.

332. Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J; Danish Head and Neck Cancer Group (DAHANCA). Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014 Dec;113(3):310-6.

331. Søes S, Daugaard IL, Sørensen BS, Carus A, Mattheisen M, Alsner J, Overgaard J, Hager H, Hansen LL, Kristensen LS. Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation. Oncoscience. 2014 May 23;1(5):367-74.

329. Hansen DC, Bassler N, Sørensen TS, Seco J. The image quality of ion computed tomography at clinical imaging dose levels. Med Phys. 2014 Nov;41(11):111908.

328. N. Bassler, D. C. Hansen, A. Lühr, B. Thomsen, J. B. Petersen, N. Sobolevsky SHIELD-HIT12A - a Monte Carlo particle transport program for ion therapy research Journal of Physics Conference Series 02/2014; 489(1).

327. Aznar MC, Persson GF, Kofoed IM, Nygaard DE, Korreman SS. Irregular breathing during 4DCT scanning of lung cancer patients: is the midventilation approach robust? Phys Med. 2014 Feb;30(1):69-75.

326. Fokdal L, Ørtoft G, Hansen ES, Røhl L, Pedersen EM, Tanderup K, Lindegaard JC. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer. Brachytherapy. 2014 Nov-Dec;13(6):554-61.

325. Mohamed SM, Aagaard T, Fokdal LU, Pedersen EM, Lindegaard JC, Tanderup K. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer. Brachytherapy. 2015 Jan-Feb;14(1):56-61.

323. Klein EE, Dong L, Paganetti H, Tanderup K. The far-reaching subject matter of medical physics in radiation oncology. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):697-700.

322. Appelt AL, Vogelius IR, Pløen J, Rafaelsen SR, Lindebjerg J, Havelund BM, Bentzen SM, Jakobsen A. Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. 2014

321. Appelt AL, Bentzen SM, Jakobsen A, Vogelius IR. Dose-response of acute urinary toxicity of long-course preoperative chemoradiotherapy for rectal cancer. Acta Oncol. 2015 Feb;54(2):179-86.

320. Aggerholm-Pedersen N, Safwat A, Bærentzen S, Nordsmark M, Nielsen OS, Alsner J, Sørensen BS. The importance of reference gene analysis of formalin-fixed, paraffin-embedded samples from sarcoma patients - an often underestimated problem. Transl Oncol. 2014 Dec;7(6):687-93.

319. Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. Magnetic Resonance Image Guided Brachytherapy. Semin Radiat Oncol. 2014 Jul;24(3):181-191.

318. Assenholt MS, Vestergaard A, Kallehauge JF, Mohamed S, Nielsen SK, Petersen JB, Fokdal L, Lindegaard JC, Tanderup K. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Brachytherapy. 2014 Jul-Aug;13(4):361-8.

317. Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c. Br J Cancer. 2014 Apr 15;110(8):2072-80.

316. Bøje CR, Dalton SO, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Overgaard J. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol. 2014 Jan;110(1):91-7

314. Quigley DA, Fiorito E, Nord S, Van Loo P, Alnæs GG, Fleischer T, Tost J, Moen Vollan HK, Tramm T, Overgaard J, Bukholm IR, Hurtado A, Balmain A, Børresen-Dale AL, Kristensen V1 The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors. Mol Oncol. 2014 Mar;8(2):273-84

313. Deasy JO, Muren LP. Advancing our quantitative understanding of radiotherapy normal tissue morbidity. Acta Oncol. 2014 May;53(5):577-9.

312. Grantzau T, Thomsen MS, Væth M, Overgaard J. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014 Jun;111(3):366-73.

311. Malinen E, Muren LP. Image guided therapy - do we get the picture? Acta Oncol. 2014 Jan;53(1):3-5.

310. Aure MR, Leivonen SK, Fleischer T, Zhu Q, Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI, Perälä M, Busato F, Touleimat N, Tost J, Børresen-Dale AL, Hautaniemi S, Troyanskaya OG, Lingjærde OC, Sahlberg KK, Kristensen VN. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol. 2013 Nov 20;14(11):R126

309. Herrmann R, Greilich S, Grzanka L, and Bassler N. Amorphous-track predictions in 'libamtrack' for alanine relative effectiveness in ion beams. Radiation Measurements 46:1551-53, 2012.

308. Thor M, Benedek H, Knöös T, Engström P, Behrens CF, Hauer AK, Sjöström D, Ceberg C. Introducing multiple treatment plan-based comparison to investigate the performance of gantry angle optimisation (GAO) in IMRT for head and neck cancer. Acta Oncol. 2012 Jul;51(6):743-51.

307. Busk M, Horsman MR. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment. Q J Nucl Med Mol Imaging. 2013 Sep;57(3):219-34.

305. Dieperink KB, Johansen C, Hansen S, Wagner L, Andersen KK, Minet LR, Hansen O. The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients. Br J Cancer. 2013 Oct 29.

304. Ringbæk TP, Weber U, Petersen JB, Thomsen B, Bassler N. Monte Carlo simulations of new 2D ripple filters for particle therapy facilities. Acta Oncol. 2013 Sep 20.

303. Christoffersen CP, Hansen D, Poulsen P, Sorensen TS. Registration-based reconstruction of four-dimensional cone beam computed tomography. IEEE Trans Med Imaging. 2013 Nov;32(11):2064-77.

302. Bjerre T, Crijns S, af Rosenschöld PM, Aznar M, Specht L, Larsen R, Keall P. Three-dimensional MRI-linac intra-fraction guidance using multiple orthogonal cine-MRI planes. Phys Med Biol. 2013 Jul 21;58(14):4943-50.

301. Bernchou U, Schytte T, Bertelsen A, Bentzen SM, Hansen O, Brink C. Time evolution of regional CT density changes in normal lung after IMRT for NSCLC. Radiother Oncol. 2013 Sep 20.

300. Hansen CR, Christiansen RL, Nielsen TB, Bertelsen AS, Johansen J, Brink C. Comparison of three immobilisation systems for radiation therapy in head and neck cancer. Acta Oncol. 2013 Sep 24.

299. Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Lengele B. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2013 Oct 31.

298. Vestergaard A, Muren LP, Søndergaard J, Elstrøm UV, Høyer M, Petersen JB. Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: A dose accumulation comparison Radiother Oncol. 2013 Dec;109(3):457-62.

297. Thörnqvist S, Hysing LB, Zolnay AG, Söhn M, Hoogeman MS, Muren LP, Bentzen L, Heijmen BJ. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer. Radiother Oncol. 2013 Oct 31.

296. Baumann M, Bodis S, Dikomey E, van der Kogel A, Overgaard J, Rodemann HP, Wouters B. Molecular radiation biology/oncology at its best: Cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. Radiother Oncol. 2013 Sep;108(3):357-61

295. Mortensen HR, Overgaard J, Jensen K, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen E, Andersen LJ, Hansen HS, Grau C; DAHANCA Group. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol. 2013 Oct;52(7):1535-42.

293. Offersen BV, Nielsen HM, Overgaard M, Overgaard J. Is regional nodes radiotherapy an alternative to surgery? Breast. 2013 Aug;22 Suppl 2:S118-28.

291. Tramm T, Hennig G, Kyndi M, Alsner J, Sørensen FB, Myhre S, Sørlie T, Overgaard J. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection. Virchows Arch. 2013 Oct 8.

290. Nielsen T, Nielsen NC, Holm TH, Ostergaard L, Horsman MR, Busk M. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia. Acta Oncol. 2013 Oct;52(7):1287-92.

288. Winther M, Alsner J, Tramm T, Nordsmark M. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer. Acta Oncol. 2013 Oct;52(7):1327-35.

286. Behrens CF, Andreasen TB, Lindberg H, Buhl SK, Vestergaard A, Elstrøm UV, Sjöström D. Quantitative image quality evaluation of pelvic computed tomography-based imaging systems: A novel concept in radiotherapy. Acta Oncol. 2013 Oct;52(7):1579-82.

285. Korsager AS, Stephansen UL, Carl J, Ostergaard LR. The use of an active appearance model for automated prostate segmentation in magnetic resonance. Acta Oncol. 2013 Oct;52(7):1374-7.

284. Nielsen MS, Nyström MW, Carl J. Potential position errors using fiducial markers for gated image guided radiotherapy. Acta Oncol. 2013 Oct;52(7):1472-6.

283. Ravn S, Holmberg M, Sørensen P, Frøkjær JB, Carl J. Differences in supratentorial white matter diffusion after radiotherapy - new biomarker of normal brain tissue damage? Acta Oncol. 2013 Oct;52(7):1314-9.

282. Vogelius IR, Håkansson K, Due AK, Aznar MC, Berthelsen AK, Kristensen CA, Rasmussen J, Specht L, Bentzen SM. Failure-probability driven dose painting. Med Phys. 2013 Aug;40(8)

281. Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol. 2014 May;53(5):605-12.

280. Kallehauge J, Nielsen T, Haack S, Peters DA, Mohamed S, Fokdal L, Lindegaard JC, Hansen DC, Rasmussen F, Tanderup K, Pedersen EM. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer. Acta Oncol. 2013 Oct;52(7):1360-8.

279. Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol. 2013 Oct;52(7):1510-9.

277. Skyt PS, Petersen JB, Yates ES, Poulsen PR, Ravkilde TL, Balling P, Muren LP. Dosimetric verification of complex radiotherapy with a 3D optically based dosimetry system: Dose painting and target tracking. Acta Oncol. 2013 Oct;52(7):1445-50.

276. Bassler N, Toftegaard J, Lühr A, Sørensen BS, Scifoni E, Krämer M, Jäkel O, Mortensen LS, Overgaard J, Petersen JB. LET-painting increases tumour control probability in hypoxic tumours. Acta Oncol. 2014 Jan;53(1):25-32.

275. Thörnqvist S, Hysing LB, Zolnay AG, Söhn M, Hoogeman MS, Muren LP, Heijmen BJ. Adaptive radiotherapy in locally advanced prostate cancer using a statistical deformable motion model. Acta Oncol. 2013 Oct;52(7):1423-9.

271. Sørensen BS, Busk M, Olthof N, Speel EJ, Horsman MR, Alsner J, Overgaard J. Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells. Radiother Oncol. 2013 Sep;108(3):500-5.

270. Thorsen LB, Thomsen MS, Overgaard M, Overgaard J, Offersen BV; on behalf of the Danish Breast Cancer Cooperative Group Radiotherapy Committee. Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study. Acta Oncol. 2013 Oct;52(7):1526-34.

269. Busk M, Jakobsen S, Horsman MR, Mortensen LS, Iversen AB, Overgaard J, Nordsmark M, Ji X, Lee DY, Raleigh JR. PET imaging of tumor hypoxia using 18F-labeled pimonidazole. Acta Oncol. 2013 Oct;52(7):1300-7.

268. Lønbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Overgaard J, Overgaard K. Lean body mass and muscle function in head and neck cancer patients and healthy individuals - results from the DAHANCA 25 study. Acta Oncol. 2013 Oct;52(7):1543-51.

267. Grau C, Høyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART) - more than a vision? Acta Oncol. 2013 Oct;52(7):1243-7.

266. Tanderup K, Beddar S, Andersen CE, Kertzscher G, Cygler JE. In vivo dosimetry in brachytherapy. Med Phys. 2013 Jul;40(7):070902.

265. Lønbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Aagaard P, Hermann AP, Overgaard J, Overgaard K. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy - Results from the randomized DAHANCA 25B trial. Radiother Oncol. 2013 Aug;108(2):314-9.

263. Schmidt ML, Hoffmann L, Kandi M, Møller DS, Poulsen PR. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol. 2013 Oct;52(7):1490-6.

261. Havelund BM, Olsen DA, Andersen RF, Spindler KL, Brandslund I, Jakobsen A, Soerensen FB. The Influence of Tissue Ischemia on Biomarker Expression in Colorectal Cancer. Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):298-307.

260. Havelund BM, Spindler KL, Ploen J, Andersen RF, Jakobsen A. Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer. Oncol Lett. 2012 Nov;4(5):1056-1060.

259. Havelund BM, Holdgaard PC, Rafaelsen SR, Mortensen LS, Theil J, Bender D, Pløen J, Spindler KL, Jakobsen A. Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer. Nucl Med Commun. 2013 Feb;34(2):155-61.

258. Korsager AS, Carl J, Ostergaard LR. MR-CT registration using a Ni-Ti prostate stent in image-guided radiotherapy of prostate cancer. Med Phys. 2013 Jun;40(6):061907.

257. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of postmastectomy breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous flap. J Plast Surg Hand Surg. 2013 Oct;47(5):374-8.

256. Thor M, Bentzen L, Hysing LB, Ekanger C, Helle SI, Karlsdóttir A, Muren LP. Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions. Radiother Oncol. 2013 May;107(2):147-52.

255. Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck Af Rosenschöld P, Petersen PM, Specht L. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol. 2013 Aug;24(8):2113-8.

254. Nesvacil N, Tanderup K, Hellebust TP, De Leeuw A, Lang S, Mohamed S, Jamema SV, Anderson C, Pötter R, Kirisits C. A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy. Radiother Oncol. 2013 Apr;107(1):20-5.

252. Søes S, Sørensen BS, Alsner J, Overgaard J, Hager H, Hansen LL, Kristensen LS. Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary Non-Small Cell Lung Cancers and brain and lymph node metastases. Lung Cancer. 2013 Aug;81(2):180-6.

251. Muren LP, Rossi C, Hug E, Lee A, Glimelius B. Establishing and expanding the indications for proton and particle therapy. Acta Oncol. 2013 Apr;52(3):459-62.

250. Worm ES, Høyer M, Fledelius W, Poulsen PR. Three-dimensional, Time-Resolved, Intrafraction Motion Monitoring Throughout Stereotactic Liver Radiation Therapy on a Conventional Linear Accelerator. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):190-7.

249. Myhre S, Lingjærde OC, Hennessy BT, Aure MR, Carey MS, Alsner J, Tramm T, Overgaard J, Mills GB, Børresen-Dale AL, Sørlie T. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins. Mol Oncol. 2013 Jun;7(3):704-18.

248. Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Specht L. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1057-65.

247. Dieperink KB, Wagner L, Hansen S, Hansen O. Embracing life after prostate cancer. A male perspective on treatment and rehabilitation. Eur J Cancer Care (Engl). 2013 Jul;22(4):549-58.

245. Lühr A, Priegnitz M, Fiedler F, Sobolevsky N, Bassler N. Dependence of simulated positron emitter yields in ion beam cancer therapy on modeling nuclear fragmentation. Appl Radiat Isot. 2013 Jan 3.

244. Thörnqvist S, Muren LP, Bentzen L, Hysing LB, Høyer M, Grau C, Petersen JB. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol. 2013 Apr;52(3):521-7.

242. Andersen ES, Noe KO, Sørensen TS, Nielsen SK, Fokdal L, Paludan M, Lindegaard JC, Tanderup K. Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy. Radiother Oncol. 2013 Apr;107(1):52-7.

241. Sapru S, Mohamed S, Fokdal L, Nkiwane K, Swamidas J, Mahantshetty U, Kirisits C, Pötter R, Christian Lindegaard J, Tanderup K. Dose to the non-involved uterine corpus with MRI guided brachytherapy in locally advanced cervical cancer. Radiother Oncol. 2013 Apr;107(1):93-8.

240. Tanderup K, Nesvacil N, Pötter R, Kirisits C. Uncertainties in image guided adaptive cervix cancer brachytherapy: Impact on planning and prescription. Radiother Oncol. 2013 Apr;107(1):1-5.

239. Nygaard DE, Persson GF, Brink C, Specht L, Korreman SS. Evaluation of methods for selecting the midventilation bin in 4DCT scans of lung cancer patients. Acta Oncol. 2013 Nov;52(8):1715-22.

238. Mohamed S, Nielsen SK, Fokdal LU, Pedersen EM, Lindegaard JC, Tanderup K Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer Radiother Oncol. 2013 Apr;107(1):32-8.

237. Bøje CR, Dalton SO, Grønborg TK, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Overgaard J. The impact of comorbidity on outcome in 12 623 Danish Head and Neck Cancer Patients: A population based study from the DAHANCA database Acta Oncol. 2013 Feb;52(2):285-93.

236. Pagh A, Vedtofte T, Lynggaard CD, Rubek N, Lonka M, Johansen J, Andersen E, Kristensen CA, von Buchwald C, Andersen M, Godballe C, Overgaard J, Grau C. The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA Acta Oncol. 2013 Feb;52(2):277-84.

234. Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, Jespersen JB, Kristensen CA, Andersen E, Godballe C, Buchwald C, Bundgaard T, Johansen J, Lambertsen K, Primdahl H, Toustrup K, Sørensen JA, Overgaard J, Grau C. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013 May;49(7):1627-33.

233. Bernchou U, Agergaard SN, Brink C. Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movement. Acta Oncol. 2013 Aug;52(6):1168-74.

232. Lyngholm CD, Christiansen PM, Damsgaard TE, Overgaard J. Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica Feb 2013, Vol. 52, No. 2: 259–269.

231. Skyt PS, Wahlstedt I, Muren LP, Petersen JB, Balling P. Temperature and temporal dependence of the optical response for a radiochromic dosimeter. Med Phys. 2012 Dec;39(12):7232-7236.

228. Mortensen HR, Jensen K, Grau C. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer. Acta Oncologica Feb 2013, Vol. 52, No. 2: 270–276.

227. Lønbro S, Dalgas U, Primdahl H, Overgaard J, Overgaard K. Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients - the DAHANCA 25A study. Acta Oncologica Feb 2013, Vol. 52, No. 2: 310–318.

226. Horsman MR, Mortensen LS, Petersen JB, Busk M, Overgaard J. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012 Nov 13;9(12):674-87.

225. Lassen P, Overgaard J. Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression. Radiother Oncol. 2012 Nov;105(2):269-70.

224. Poulsen PR, Schmidt ML, Keall P, Worm ES, Fledelius W, Hoffmann L. A method of dose reconstruction for moving targets compatible with dynamic treatments. Med Phys. 2012 Oct;39(10):6237-6246.

223. Holzscheiter MH, Bassler N, Dosanjh M, Sørensen BS, Overgaard J. A community call for a dedicated radiobiological research facility to support particle beam cancer therapy. Radiother Oncol. 2012 Sep 14.

222. Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer. Acta Oncol. 2012 Jul;51(6):722-9.

221. Andersen ES, Muren LP, Sørensen TS, Noe KO, Thor M, Petersen JB, Høyer M, Bentzen L, Tanderup K. Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer. Phys Med Biol. 2012 Nov 7;57(21):7089-100.

220. Laursen LV, Elstrøm UV, Vestergaard A, Muren LP, Petersen JB, Lindegaard JC, Grau C, Tanderup K. Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer. Radiother Oncol. 2012 Nov;105(2):220-5.

219. Persson GF, Nygaard DE, Hollensen C, Munck af Rosenschöld P, Mouritsen LS, Due AK, Berthelsen AK, Nyman J, Markova E, Roed AP, Roed H, Korreman S, Specht L. Interobserver delineation variation in lung tumour stereotactic body radiotherapy. Br J Radiol. 2012 Sep;85(1017):e654-60.

217. Appelt AL, Vogelius IR, Bentzen SM. Modern Hypofractionation Schedules for Tangential Whole Breast Irradiation Decrease the Fraction Size-corrected Dose to the Heart. Clin Oncol (R Coll Radiol). 2013 Mar;25(3):147-52.

216. Mortensen LS, Johansen J, Kallehauge J, Primdahl H, Busk M, Lassen P, Alsner J, Sørensen BS, Toustrup K, Jakobsen S, Petersen J, Petersen H, Theil J, Nordsmark M, Overgaard J. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial. Radiother Oncol. 2012 Oct;105(1):14-20.

215. Busk M, Mortensen LS, Nordsmark M, Overgaard J, Jakobsen S, Hansen KV, Theil J, Kallehauge JF, D'Andrea FP, Steiniche T, Horsman MR. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice. Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):186-97

214. Nawroth I, Alsner J, Deleuran BW, Dagnaes-Hansen F, Yang C, Horsman MR, Overgaard J, Howard KA, Kjems J, Gao S. Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model. Acta Oncol. 2013 Nov;52(8):1730-8.

213. Hansen DC, Lühr A, Sobolevsky N, Bassler N. Optimizing SHIELD-HIT for carbon ion treatment. Phys Med Biol. 2012 Apr 21;57(8):2393-409.

212. Lühr A, Hansen DC, Teiwes R, Sobolevsky N, Jäkel O, Bassler N. The impact of modeling nuclear fragmentation on delivered dose and radiobiology in ion therapy. Phys Med Biol. 2012 Aug 21;57(16):5169-85.

211. Appelt AL, Pløen J, Vogelius IR, Bentzen SM, Jakobsen A. Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):74-80.

209. Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis. 2011 Jul;13(7):732-42.

208. Nielsen MB, Rasmussen P, Keller J, Laurberg S. Preliminary experience with external hemipelvectomy for locally advanced and recurrent pelvic carcinoma. Colorectal Dis. 2012 Feb;14(2):152-6.

206. Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Kristensen CA, Specht L. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma. Strahlenther Onkol. 2012 Aug;188(8):671-6.

205. Lock MI, Hoyer M, Bydder SA, Okunieff P, Hahn CA, Vichare A, Dawson LA. An international survey on liver metastases radiotherapy. Acta Oncol. 2012 May;51(5):568-74.

204. Høyer M, Muren LP. Stereotactic body radiation therapy - A discipline with Nordic origin and profile. Acta Oncol. 2012 May;51(5):564-7.

203. Norling R, Grau C, Nielsen MB, Homøe P, Sørensen JA, Lambertsen K, Bundgaard T, Mäkitie A et al. Radiological imaging of the neck for initial decision-making in oral squamous cell carcinomas--a questionnaire survey in the Nordic countries. Acta Oncol. 2012 Mar;51(3):355-61.

201. Offersen BV, Brodersen HJ, Nielsen MM, Overgaard J, Overgaard M. Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes? Breast Care (Basel). 2011 Oct;6(5):347-351.

200. Worm ES, Høyer M, Fledelius W, Nielsen JE, Larsen LP, Poulsen PR. On-line use of three-dimensional marker trajectory estimation from cone-beam computed tomography projections for precise setup in radiotherapy for targets with respiratory motion. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e145-51.

199. Brodin NP, Vogelius IR, Maraldo MV, Munck Af Rosenschöld P, Aznar MC, Kiil-Berthelsen A, Nilsson P, Björk-Eriksson T, Specht L, Bentzen SM. Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer. 2012 Nov 1;118(21):5432-40.

198. Overgaard J and Bartelink H Introduction: towards predicting outcome of radiotherapy-at last. Semin Radiat Oncol. 2012 Apr;22(2):87-90.

197. D'Andrea FP, Safwat A, Burns JS, Kassem M, Horsman MR, Overgaard J. Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells. Int J Radiat Biol. 2012 Jun;88(6):457-65.

196. Lievens Y, Grau C. Health Economics in Radiation Oncology: Introducing the ESTRO HERO project. Radiother Oncol. 2012 Apr;103(1):109-12.

195. Lindegaard JC and Tanderup K Counterpoint: Time to retire the parametrial boost Brachytherapy 11:80-83, 2012.

194. Toustrup K, Sørensen BS, Alsner J, Overgaard J. Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Semin Radiat Oncol. 2012 Apr;22(2):119-27.

192. Keall PJ, Sawant A, Cho B, Ruan D, Wu J, Poulsen P, Petersen J, Newell LJ, Cattell H, Korreman S. Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):312-20.

190. Poulsen PR, Fledelius W, Cho B, Keall P. Image-Based Dynamic Multileaf Collimator Tracking of Moving Targets During Intensity-Modulated Arc Therapy. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e265-71.

189. Hansen AE, Kristensen AT, Law I, Jørgensen JT, McEvoy FJ, Busk M, van der Kogel AJ, Bussink J, Kjær A, Engelholm SA. Initial non-invasive and invasive experiences using [64Cu]ATSM in spontaneous canine tumors. Cancer Imaging. 2011 Oct 3;11 Spec No A:S42-3.

188. Mendez Romero A and Høyer M. Radiation therapy for liver metastases. Curr Opin Support Palliat Care. 2012 Mar;6(1):97-102.

187. Høyer M, Swaminath A, Bydder S, Lock M, Romero AM, Kavanagh B, Goodman KA, Okunieff P, Dawson LA. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1047-57.

186. Høyer M, Thor M, Thörnqvist S, Søndergaard J, Lassen-Ramshad Y, Paul Muren L. Advances in radiotherapy: from 2D to 4D. Cancer Imaging. 2011 Oct 3;11 Spec No A:S147-52.

185. Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, Pedersen EM, van Limbergen E, Haie-Meder C, Pötter R. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012 Apr;103(1):113-22.

183. Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer. Radiother Oncol. 2012 Apr;103(1):69-75.

182. Tideman Arp D, Carl J. EXACTRAC x-ray and beam isocenters-What's the difference? Med Phys. 2012 Mar;39(3):1418-23.

181. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct Therapeutic Applications of Calcium Electroporation to Effectively Induce Tumor Necrosis. Cancer Res. 2012 Mar 15;72(6):1336-41.

180. Larsen EK, Nielsen T, Wittenborn T, Rydtoft LM, Lokanathan AR, Hansen L, Ostergaard L, Kingshott P, Howard KA, Besenbacher F, Nielsen NC, Kjems J. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors. Nanoscale. 2012 Apr 7;4(7):2352-61.

179. Wittenborn T, Nielsen T, Nygaard JV, Larsen EK, Thim T, Rydtoft LM, Vorup-Jensen T, Kjems J, Nielsen NC, Horsman MR, Falk E. Ultrahigh-field DCE-MRI of angiogenesis in a novel angiogenesis mouse model. J Magn Reson Imaging. 2012 Mar;35(3):703-10.

176. Maraldo MV, Brodin NP, Vogelius IR, Aznar MC, Munck Af Rosenschöld P, Petersen PM, Specht L. Risk of Developing Cardiovascular Disease after Involved Node Radiotherapy versus Mantle Field for Hodgkin Lymphoma Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1232-7.

175. Korreman S, Persson G, Nygaard D, Brink C, Juhler-Nøttrup T. Respiration-correlated image guidance is the most important radiotherapy motion management strategy for most lung cancer patients. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1338-43.

174. Hoff CM Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy Acta Oncol. 2012 Apr;51(4):419-32.

172. Kaiser FJ, Bassler N, Tölli H, Jäkel O. Initial recombination in the track of heavy charged particles: Numerical solution for air filled ionization chambers. Acta Oncol. 2012 Mar;51(3):368-75.

171. Hansen AE, Kristensen AT, Law I, McEvoy FJ, Kjær A, Engelholm SA. Multimodality functional imaging of spontaneous canine tumors using (64)Cu-ATSM and (18)FDG PET/CT and dynamic contrast enhanced perfusion CT. Radiother Oncol. 2012 Mar;102(3):424-8.

170. Carl J, Nielsen J, Nielsen MS, Zepernick PR, Kjaergaard B, Jensen HK. A new lung stent tested as fiducial marker in a porcine model. Radiother Oncol. 2012 Feb;102(2):297-302.

168. Hoffmann L, Jørgensen MB, Muren LP, Petersen JB. Clinical validation of the Acuros XB photon dose calculation algorithm, a grid-based Boltzmann equation solver. Acta Oncol. 2012 Mar;51(3):376-85.

167. Nielsen TB, Hansen VN, Westberg J, Hansen O, Brink C. A dual centre study of setup accuracy for thoracic patients based on Cone-Beam CT data. Radiother Oncol. 2012 Feb;102(2):281-6.

166. Fledelius W, Worm E, Elstro̸m UV, Petersen JB, Grau C, Ho̸yer M, Poulsen PR. Robust automatic segmentation of multiple implanted cylindrical gold fiducial markers in cone-beam CT projections. Med Phys. 2011 Dec;38(12):6351.

165. D'Andrea FP, Horsman MR, Kassem M, Overgaard J, Safwat A. Tumourigenicity and radiation resistance of mesenchymal stem cells. Acta Oncol. 2012 May;51(5):669-79.

164. Wojdacz TK, Thestrup BB, Overgaard J, Hansen LL. Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn Pathol. 2011 Nov 30;6(1):116.

162. Schmitz T, Blaickner M, Ziegner M, Bassler N, Grunewald C, Kratz JV, Schütz C, Langguth P, Sharpe P, Palmans H, Holzscheiter MH, Otto G, Hampel G. Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies. Acta Oncol. 2011 Aug;50(6):817-22.

161. Hysing LB, Söhn M, Muren LP, Alber M. A coverage probability based method to estimate patient-specific small bowel planning volumes for use in radiotherapy. Radiother Oncol. 2011 Sep;100(3):407-11.

160. Busk M, Bohn AB, Skals M, Wang T, Horsman MR. Combretastatin-induced hypertension and the consequences for its combination with other therapies. Vascul Pharmacol. 2011 Jan-Feb;54(1-2):13-7.

159. Bertelsen LB, Shen YY, Nielsen T, Stødkilde-Jørgensen H, Lloyd GK, Siemann DW, Horsman MR. Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. Int J Radiat Biol. 2011 Nov;87(11):1126-34.

158. Waldeland E, Helt-Hansen J, Malinen E Characterization of lithium formate EPR dosimeters for high dose applications – Comparison with alanine Radiation Measurements 46:213-8, 2011.

157. Rosenschöld PM, Engelholm S, Ohlhues L, Law I, Vogelius I, Engelholm SA. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Acta Oncol. 2011 Aug;50(6):777-83.

156. Lühr A, Hansen DC, Sobolevsky N, Palmans H, Rossomme S, Bassler N. Fluence correction factors and stopping power ratios for clinical ion beams. Acta Oncol. 2011 Aug;50(6):797-805.

155. Haack S, Jespersen SN, Fokdal L, Lindegaard JC, Kallehauge JF, Tanderup K, Pedersen EM. Diffusion Weighted MRI (DWI) for brachytherapy in locally advanced cervical cancer – determining the degree of distortion at 1.5T and 3T MRI. IFMBE Proceedings 34, pp. 172-175, 2011.

153. Noe KØ, Tanderup K, Sørensen TS Surface membrane based bladder registration for evaluation of accumulated dose during brachytherapy in cervical cancer IEEE International Symposium on Biomedical Imaging (ISBI) 2011. 4 pp. 1253-1256.

152. Appelt AL, Vogelius IR. A method to adjust radiation dose-response relationships for clinical risk factors. Radiother Oncol. 2012 Mar;102(3):352-4.

151. Toustrup K, Sørensen BS, Lassen P, Wiuf C, Alsner J, Overgaard J; On behalf of the Danish Head and Neck Cancer Group (DAHANCA). Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck Radiother Oncol. 2012 Jan;102(1):122-9.

150. Kertzscher G , Andersen CE , Siebert F-A , Nielsen SK ,Lindegaard JC, Tanderup K Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al2O3:C dosimetry and a novel statistical error decision criterion Radiother Oncol. 2011 Sep;100(3):456-62.

149. Yates ES, Balling P, Petersen JB, Christensen MN, Skyt PS, Bassler N, Kaiser FJ, Muren LP. Characterization of the optical properties and stability of Presage™ following irradiation with photons and carbon ions. Acta Oncol. 2011 Aug;50(6):829-34.

148. Lassen-Ramshad Y, Vestergaard A, Muren LP, Høyer M, Petersen JB. Plan robustness in proton beam therapy of a childhood brain tumour. Acta Oncol. 2011 Aug;50(6):791-6.

147. Kaiser FJ, Bassler N, Tölli H, and Jäkel O Liquid ionization chambers for LET determination Radiation Measurements 45 (2010) 1109-1111.

146. Andersen CE, Damkjær SMS, Kertzscher G, Greilich S, and Aznar MC Fiber-coupled radioluminescence dosimetry with saturated Al2O3:C crystals: Characterization in 6 and 18 MV photon beams Radiation Measurements 46 (2011) 1090-1098

145. Kertzscher G, Andersen CE, Edmund JM, and Tanderup K Stem signal suppression in fiber-coupled Al2O3:C dosimetry for 192 Ir brachytherapy Radiation Measurements 46:2020-24, 2011.

144. Lühr A, Toftegaard J, Kantemiris I, Hansen DC, Bassler N. Stopping power for particle therapy: The generic library libdEdx and clinically relevant stopping-power ratios for light ions. Int J Radiat Biol. 2011 Jul 19.

143. Hansen DC, Lühr A, Herrmann R, Sobolevsky N, Bassler N. Recent improvements in the SHIELD-HIT code. Int J Radiat Biol. 2012 Jan;88(1-2):195-9.

142. Havelund BM, Sørensen FB, Lindebjerg J, Spindler KL, Jakobsen A. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Res. 2011 May;31(5):1559-65.

141. Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Deng L, Broaddus R, Lluch A, Aparicio S, Brown P, Pusztai L, Symmans WF, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Clin Proteomics. 2011 Jul 8;8(1):11.

140. Fokdal L, Tanderup K, Nielsen SK, Christensen HK, Røhl L, Pedersen EM, Schønemann NK, Lindegaard JC. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol. 2011 Sep;100(3):473-9.

139. Offersen B, Højris I, Overgaard M. Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer - Is it still an issue? Radiother Oncol. 2011 Aug;100(2):157-9.

138. Thor M, Petersen JB, Bentzen L, Høyer M, Muren LP. Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer. Acta Oncol. 2011 Aug;50(6):918-25.

137. Thörnqvist S, Bentzen L, Petersen JB, Hysing LB, Muren LP. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques. Acta Oncol. 2011 Aug;50(6):926-34.

136. Skyt PS, Balling P, Petersen JB, Yates ES, Muren LP. Temperature dependence of the dose response for a solid-state radiochromic dosimeter during irradiation and storage Med Phys. 2011 May;38(5):2806-11

135. Bertelsen A, Schytte T, Bentzen SM, Hansen O, Nielsen M, Brink C. Radiation dose response of normal lung assessed by Cone Beam CT - A potential tool for biologically adaptive radiation therapy Radiother Oncol. 2011 Sep;100(3):351-5.

134. Bertelsen A, Lorenzen EL, and Brink C Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate Med Phys. 2011 Aug;38(8):4802-10.

133. Ravkilde T, Keall PJ, Højbjerre K, Fledelius W, Worm E, Poulsen PR. Geometric accuracy of dynamic MLC tracking with an implantable wired electromagnetic transponder. Acta Oncol. 2011 Aug;50(6):944-51.

132. Nyeng TB, Kallehauge JF, Høyer M, Petersen JB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol. 2011 Aug;50(6):897-907.

131. Rylander S, Thörnqvist S, Haack S, Pedersen EM, Muren LP. Intensity profile based measurement of prostate gold markers influence on 1.5 and 3T diffusion-weighted MR images. Acta Oncol. 2011 Aug;50(6):866-72.

130. Fledelius W, Keall PJ, Cho B, Yang X, Morf D, Scheib S, Poulsen PR. Tracking latency in image-based dynamic MLC tracking with direct image access. Acta Oncol. 2011 Aug;50(6):952-9.

129. Baker M, Nielsen M, Hansen O, Jahn JW, Korreman S, Brink C. Isotoxic Dose Escalation in the Treatment of Lung Cancer by Means of Heterogeneous Dose Distributions in the Presence of Respiratory Motion. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):849-55.

127. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer Clin Cancer Res. 2009 Jun 1;15(11):3654-62.

126. Poulsen PR, Carl J, Nielsen J, Nielsen MS, Thomsen JB, Jensen HK, Kjærgaard B, Zepernick PR, Worm E, Fledelius W, Cho B, Sawant A, Ruan D, Keall PJ. Megavoltage Image-Based Dynamic Multileaf Collimator Tracking of a NiTi Stent in Porcine Lungs on a Linear Accelerator Int J Radiat Oncol Biol Phys. 2011 May 21.

125. Toustrup K, Sørensen BS, Nordsmark M, Busk M, Wiuf C, Alsner J, Overgaard J. Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer Cancer Res. 2011 Sep 1;71(17):5923-31.

124. Brodin NP, Rosenschöld PM, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, Lannering B, Björk-Eriksson T. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma Acta Oncol. 2011 Aug;50(6):806-16.

123. Boejen A, Grau C. Virtual reality in radiation therapy training Surgical Oncology 20 (2011) 185-188

122. Vogelius IR, Westerly DC, Aznar MC, Cannon GM, Korreman SS, Mackie TR, Mehta MP, Bentzen SM. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer Acta Oncol. 2011 Aug;50(6):772-6.

121. D'Andrea FP, Safwat A, Kassem M, Gautier L, Overgaard J, Horsman MR. Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance Radiother Oncol. 2011 Jun;99(3):373-8.

120. Mortensen LS, Busk M, Nordsmark M, Jakobsen S, Theil J, Overgaard J, Horsman MR. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: A preclinical study Radiother Oncol. 2011 Jun;99(3):418-23.

119. Sørensen BS, Vestergaard A, Overgaard J, Præstegaard LH. Dependence of cell survival on instantaneous dose rate of a linear accelerator Radiother Oncol. 2011 Jul 5.

118. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of postmastectomy breast reconstruction Acta Oncol. 2011 Oct;50(7):1053-61.

117. Sørensen BS, Overgaard J, Bassler N. In vitro RBE-LET dependence for multiple particle types Acta Oncol. 2011 Aug;50(6):757-62.

116. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - Results from the randomized DAHANCA 5 and 7 trials Acta Oncol. 2011 Oct;50(7):1006-14.

115. Elstrøm UV, Muren LP, Petersen JB, Grau C. Evaluation of image quality for different kV cone-beam CT acquisition and reconstruction methods in the head and neck region Acta Oncol. 2011 Aug;50(6):908-17.

114. Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours Acta Oncol. 2011 Aug;50(6):823-8.

113. Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers Clin Proteomics. 2010 Dec;6(4):129-151.

112. Busk M, Walenta S, Mueller-Klieser W, Steiniche T, Jakobsen S, Horsman MR, Overgaard J. Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment. Radiother Oncol. 2011 Jun;99(3):404-11.

111. Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: A Literature-Based Meta-Analysis. Cancer. 2011 May 12.

110. Aarup LR, Nahum AE, Zacharatou C, Juhler-Nøttrup T, Knöös T, Nyström H, Specht L, Wieslander E, Korreman SS. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. Radiother Oncol. 2009 Jun;91(3):405-14.

109. Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T. In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome. PLoS One. 2010 Nov 19;5(11):e14002.

108. Ceberg S, Gagne I, Gustafsson H, Scherman JB, Korreman SS, Kjaer-Kristoffersen F, Hilts M, Bäck SA RapidArc treatment verification in 3D using polymer gel dosimetry and Monte Carlo simulation Phys Med Biol. 2010 Sep 7;55(17):4885-98.

106. Logadóttir Á, Korreman S, Petersen PM. Comparison of the accuracy and precision of prostate localization with 2D-2D and 3D images. Radiother Oncol. 2011 Feb;98(2):175-80.

104. Poulsen PR, Fledelius W, Keall PJ, Weiss E, Lu J, Brackbill E, Hugo GD. A method for robust segmentation of arbitrarily shaped radiopaque structures in cone-beam CT projections Med Phys. 2011 Apr;38(4):2151-6.

103. Poulsen PR, Cho B, Keall PJ. Real-time prostate trajectory estimation with a single imager in arc radiotherapy: a simulation study. Phys Med Biol. 2009 Jul 7;54(13):4019-35.

102. Poulsen PR, Cho B, Keall PJ Prediction of position estimation errors for 3D target trajectories estimated from cone-beam CT projections Proceedings of XVIth ICCR, Amsterdam 2010

101. Aznar MC, Korreman SS, Pedersen AN, Persson GF, Josipovic M, Specht L. Evaluation of dose to cardiac structures during breast irradiation. Br J Radiol. 2010 Dec 15.

100. Jørgensen MK, Hoffmann L, Petersen JB, Praestegaard LH, Hansen R, Muren LP. Tolerance levels of EPID-based quality control for volumetric modulated arc therapy Med Phys. 2011 Mar;38(3):1425-34.

99. Hansen AE, McEvoy F, Engelholm SA, Law I, Kristensen AT. FDG PET/CT imaging in canine cancer patients Vet Radiol Ultrasound. 2011 Mar-Apr;52(2):201-6.

98. Hansen AE, Kristensen AT, Law I, Jørgensen JT, Engelholm SA. Hypoxia-inducible factors--regulation, role and comparative aspects in tumourigenesis Vet Comp Oncol. 2011 Mar;9(1):16-37.

97. Lühr A, Hansen DC, Jäkel O, Sobolevsky N, Bassler N. Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy Phys Med Biol. 2011 Apr 21;56(8):2515-33.

96. Beierholm AR, Ottosson RO, Lindvold LR, Behrens CF, Andersen CE. Characterizing a pulse-resolved dosimetry system for complex radiotherapy beams using organic scintillators Phys Med Biol. 2011 May 21;56(10):3033-45.

95. Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, and Brink C. Influence of dose calculation algorithms on the predicted dose distributions and NTCP values for NSCLC patients Med Phys. 2011 May;38(5):2412-8.

93. Fog LS, Rasmussen JF, Aznar M, Kjær-Kristoffersen F, Vogelius IR, Engelholm SA, Bangsgaard JP. A closer look at RapidArc® radiosurgery plans using very small fields Phys Med Biol. 2011 Mar 21;56(6):1853-63.

92. Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen E, Johansen J, Andersen LJ, Grau C, Overgaard J The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol. 2011 Mar 21.

91. Wojdacz TK, Møller TH, Thestrup BB, Kristensen LS, Hansen LL. Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies Expert Rev Mol Diagn. 2010 Jul;10(5):575-80.

90. Horsman MR, Bohn AB, Busk M. Vascular targeting therapy: potential benefit depends on tumor and host related effects Exp Oncol. 2010 Sep;32(3):143-8.

89. Hokland SL, Nielsen T, Busk M, Horsman MR. Imaging tumour physiology and vasculature to predict and assess response to heat Int J Hyperthermia. 2010;26(3):264-72.

88. Poulsen PR, Cho B, Sawant A, Keall PJ. Implementation of a new method for dynamic multileaf collimator tracking of prostate motion in arc radiotherapy using a single kV imager Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):914-23

87. Poulsen PR, Cho B, Ruan D, Sawant A, Keall PJ Dynamic multileaf collimator tracking of respiratory target motion based on a single kilovoltage imager during arc radiotherapy Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):600-7

86. Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ Detailed analysis of latencies in image-based dynamic MLC tracking Med Phys. 2010 Sep;37(9):4998-5005.

85. Herrmann R, Jäkel O, Palmans H, Sharpe P, Bassler N Dose response of alanine detectors irradiated with carbon ion beams Med Phys. 2011 Apr;38(4):1859-66.

84. Maeda Y, Høyer M, Lundby L, Buntzen S, Laurberg S. Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy Radiother Oncol. 2010 Oct;97(1):108-12

83. Greilich S, Grzanka L, Bassler N, Andersen CE, and Jäkel O. Amorphous track models: a numerical comparison study Radiation Measurements. 45, 10, p1406-09.

82. Pedersen K, Wiechec E, Madsen BE, Overgaard J, Hansen LL. A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA) BMC Res Notes. 2010 Jun 26;3:179

81. Busk M, Toustrup K, Soerensen BS, Alsner J, Horsman MR, Jakobsen S, Overgaard J. In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors BMC Cancer. 2011 Feb 9;11(1):63.

80. Sørensen TS, Noe KØ, Christoffersen C, Kristiansen M, Mouridsen K, Østerby O, Brix L. Active Contours in Optical Flow Fields for Image Sequence Segmentation. IEEE International Symposium on Biomedical Imaging (ISBI) 2010 pp. 916-919.

79. Nygaard DE, Persson GF, Munck af Rosenschöld P, Specht L, Roed AP, Korreman SS. Evaluation of a semi-automatic and a manual visual method for selecting the midventilation bin in 4DCT scans of lung cancer patients. ICCR proceedings, 2010 (in press)

78. Maeda Y, Høyer M, Lundby L, Norton C. Faecal incontinence following radiotherapy for prostate cancer: A systematic review. Radiother Oncol. 2011 Feb;98(2):145-53.

77. Carl J, Nielsen J, Holmberg M, Larsen EH, Fabrin K, Fisker RV Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncol. 2011 May;50(4):547-54.

76. Aznar MC, Petersen PM, Logadottir A, Lindberg H, Korreman SS, Kjær-Kristoffersen F, Engelholm SA. Rotational radiotherapy for prostate cancer in clinical practice Radiother Oncol. 2010 Dec;97(3):480-4

75. Persson GF, Nygaard DE, af Rosenschöld PM, Vogelius IR, Josipovic M, Specht L, Korreman SS. Artifacts in conventional computed tomography (CT) and free breathing four-dimensional CT induce uncertainty in gross tumor volume determination Int J Radiat Oncol Biol Phys. 2010 Dec 14.

74. Skyt PS, Balling P, Petersen JB, Yates ES, and Muren LP. Effect of irradiation and storage temperature on PRESAGE™ dose response Journal of Physics:Conference Series 250 (2010)

73. Wiechec E, Wiuf C, Overgaard J, Hansen LL. High Resolution Melting (HRM) analysis for mutation screening of RGSL1, RGS16 and RGS8 in breast cancer Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):397-407.

72. West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, Coles C, De Ruyck K, De Ruysscher D, Dunning A, Elliott R, Fachal L, Hall J, Haustermans K, Herskind C, Hoelscher T, Imai T, Iwakawa M, Jones D, Kulich C; EQUAL-ESTRO, Langendijk JH, O'Neils P, Ozsahin M, Parliament M, Polanski A, Rosenstein B, Seminara D, Symonds P, Talbot C, Thierens H, Vega A, West C, Yarnold J Establishment of a Radiogenomics Consortium Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1295-6

71. Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren LP A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer Acta Oncol. 2010 Oct;49(7):1069-76

69. Petit SF, Dekker AL, Seigneuric R, Murrer L, van Riel NA, Nordsmark M, Overgaard J, Lambin P, Wouters BG. Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study Phys Med Biol. 2009 Apr 7;54(7):2179-96.

68. Offersen BV, Knap MM, Horsman MR, Verheijen J, Hanemaaijer R, Overgaard J. Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival Acta Oncol. 2010 Nov;49(8):1283-7

67. af Rosenschöld PM, Aznar MC, Nygaard DE, Persson GF, Korreman SS, Engelholm SA, Nyström H. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer Acta Oncol. 2010 Oct;49(7):1141-8.

65. Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients Acta Oncol. 2010 Oct;49(7):1077-84

64. Kantemiris I, Angelopoulos A, Bassler N, Giokaris N, Holzscheiter MH, Karaiskos P, Kalogeropoulos TE; AD-4/ACE Collaboration. Real-time imaging for dose evaluation during antiproton irradiation Phys Med Biol. 2010 Mar 7;55(5):N123-31

63. Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, Dumas I, Hudej R, Lowe G, Wills R, Tanderup K; Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy Radiother Oncol. 2010 Aug;96(2):153-60

62. Bassler N. Radiation damage in charge-coupled devices Radiat Environ Biophys. 2010 Aug;49(3):373-8

61. Eriksen JG, Overgaard M. Late onset of skin toxicity induced by EGFr-inhibitors Radiother Oncol. 2009 Feb;90(2):280-1

60. Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen J, Overgaard J. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - Results from the randomized DAHANCA 5 study Radiother Oncol. 2011 Jan;98(1):28-33

59. Kaiser FJ, Bassler N, Jäkel O. COTS Silicon diodes as radiation detectors in proton and heavy charged particle radiotherapy 1. Radiat Environ Biophys. 2010 Aug;49(3):365-71.

58. Schmitz T, Blaickner M, Schütz C, Wiehl N, Kratz JV, Bassler N, Holzscheiter MH, Palmans H, Sharpe P, Otto G, Hampel G. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz. Acta Oncol. 2010 Oct;49(7):1165-9

57. Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, Pötter R, Lindegaard J, Tanderup K. Parametrial Boost Using Midline Shielding Results in an Unpredictable Dose to Tumor and Organs at Risk in Combined External Beam Radiotherapy and Brachytherapy for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2010 Aug 26.

56. Tanderup K, Pötter R, Lindegaard JC, Berger D, Wambersie A, Kirisits C PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy Radiother Oncol. 2010 Dec;97(3):495-500.

55. Partridge M, Yamamoto T, Grau C, Høyer M, Muren LP Imaging of normal lung, liver and parotid gland function for radiotherapy Acta Oncol. 2010 Oct;49(7):997-1011

54. Nawroth I, Alsner J, Behlke MA, Besenbacher F, Overgaard J, Howard KA, Kjems J Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis Radiother Oncol. 2010 Oct;97(1):143-8.

53. Korreman SS, Ulrich S, Bowen S, Deveau M, Bentzen SM, Jeraj R. Feasibility of dose painting using volumetric modulated arc optimization and delivery. Acta Oncol. 2010 Oct;49(7):964-71.

52. Due AK, Korreman S, Bentzen SM, Tomé W, Bender E, Aznar M, Vogelius I, Berthelsen AK, Kristensen CA, Specht L. Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes. Acta Oncol. 2010 Oct;49(7):984-90.

51. Vogelius IS, Westerly DC, Cannon GM, Bentzen SM. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol. 2010 Oct;49(7):1052-7.

50. Grau C, Olsen DR, Overgaard J, Høyer M, Lindegaard JC, Muren LP. Biology-guided adaptive radiation therapy - presence or future? Acta Oncol. 2010 Oct;49(7):884-7.

49. Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Ostergaard L, Ley CD, Kristjansen PE, Horsman MR. Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates. Acta Oncol. 2010 Oct;49(7):906-13.

48. Busk M, Munk OL, Jakobsen S, Wang T, Skals M, Steiniche T, Horsman MR, Overgaard J. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. Acta Oncol. 2010 Oct;49(7):922-33.

47. Mortensen LS, Buus S, Nordsmark M, Bentzen L, Munk OL, Keiding S, Overgaard J. Identifying hypoxia in human tumors: A correlation study between (18)F-FMISO PET and the Eppendorf oxygen-sensitive electrode. Acta Oncol. 2010 Oct;49(7):934-40.

46. Haack S, Pedersen EM, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol. 2010 Oct;49(7):978-83.

45. Kallehauge JF, Tanderup K, Haack S, Nielsen T, Muren LP, Fokdal L, Lindegaard JC, Pedersen EM. Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol. 2010 Oct;49(7):1017-22.

44. Thörnqvist S, Petersen JB, Høyer M, Bentzen LN, Muren LP. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration. Acta Oncol. 2010 Oct;49(7):1023-32.

43. Wright P, Muren LP, Høyer M, Malinen E. Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling. Acta Oncol. 2010 Oct;49(7):1045-51.

41. Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ. Dynamic MLC tracking of moving targets with a single kV imager for 3D conformal and IMRT treatments. Acta Oncol. 2010 Oct;49(7):1092-100.

39. Herrmann R, Carl J, Jäkel O, Bassler N, Petersen JB. Investigation of the dosimetric impact of a Ni-Ti fiducial marker in carbon ion and proton beams. Acta Oncol. 2010 Oct;49(7):1160-4.

38. Schytte T, Hansen O, Stolberg-Rohr T, Brink C. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer. Acta Oncol. 2010 Oct;49(7):1058-60

37. Gottlieb KL, Hansen CR, Hansen O, Westberg J, Brink C. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT Acta Oncol. 2010 Oct;49(7):1192-8

36. Worm ES, Hansen AT, Petersen JB, Muren LP, Præstegaard LH, Høyer M. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung Acta Oncol. 2010 Oct;49(7):1177-83.

35. Persson GF, Nygaard DE, Brink C, Jahn JW, Munck af Rosenschöld P, Specht L, Korreman SS. Deviations in delineated GTV caused by artefacts in 4DCT Radiother Oncol. 2010 Jul;96(1):61-6

34. Eriksen JG, Lassen P, Overgaard J. Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab? Lancet Oncol. 2010 Apr;11(4):312-3.

33. Ottosson RO, Karlsson A, Behrens CF Pareto front analysis of 6 and 15 MV dynamic IMRT for lung cancer using pencil beam, AAA and Monte Carlo Phys Med Biol. 2010 Aug 21;55(16):4521-33

32. Carl J, Jensen HK, Nielsen J, Nielsen MS, Schmid M, Loeschke S Bronchoscopic insertion and removal of a new fiducial Nine Ten stent fields in the Göttingen mini-pig lung: A feasibility study-I. In press

30. Bassler N, Holzscheiter M Calculated LET Spectrum from Antiproton Beams Stopping in Water Acta Oncol. 48: 223-226, 2009.

29. Bassler N, Jäkel O, Søndergaard CS, Petersen JB Dose-and LET-painting with particle therapy Acta Oncol. 2010 Oct;49(7):1170-6.

28. Bassler N, Holzscheiter MH, Petersen JB Neutron Fluence in Antiproton Radiotherapy, Measurements and Simulations Acta Oncol. 2010 Oct;49(7):1149-59.

26. Søndergaard J, Olsen KO, Muren LP, Elstrøm UV, Grau C, Høyer M A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall Acta Oncol. 2010 Oct;49(7):1109-15

25. Sørensen BS, Toustrup K, Horsman MR, Overgaard J, Alsner J Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro Acta Oncol. 2010 Oct;49(7):895-905.

24. Olsen DR, Overgaard J Leveraging clinical performance by technological excellence - The case of particle therapy Radiother Oncol. 2010 Apr;95(1):1-2

23. K. Ø. Noe, T.S. Sørensen Solid Mesh Registration for Radiotherapy Treatment Planning Lecture Notes in Computer Science 2010; volume 5958 pp. 59-70

22. Tanderup K, Georg D, Pötter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy Semin Radiat Oncol. 2010 Apr;20(2):121-9

21. Overgaard J, Mohanti BK, Begum N, Ali R, Agarwal JP, Kuddu M, Bhasker S, Tatsuzaki H, Grau C. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial Lancet Oncol. 2010 Jun;11(6):553-60

20. Bertelsen A, Hansen CR, Johansen J, Brink C Single Arc Volumetric Modulated Arc Therapy of head and neck cancer Radiother Oncol. 2010 May;95(2):142-8

19. Bassler N, Kantemiris I, Karaiskos P, Engelke J, Holzscheiter MH, Petersen JB. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams Radiother Oncol. 2010 Apr;95(1):87-93

18. Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, Fokdal L, Lindegaard JC. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol. 2010 Feb;94(2):173-80

17. Westberg J, Jensen HR, Bertelsen A, Brink C Reduction of Cone-Beam CT scan time without compromising the accuracy of the image registration in IGRT Acta Oncol. 2010;49(2):225-9

16. Falk M, Af Rosenschöld PM, Keall P, Cattell H, Cho BC, Poulsen P, Povzner S, Sawant A, Zimmerman J, Korreman S. Real-time dynamic MLC tracking for inversely optimized arc radiotherapy Radiother Oncol. 2010 Feb;94(2):218-23

15. Karlsdottir A, Muren LP, Wentzel-Larsen T, Johannessen DC, Haukaas SA, Halvorsen OJ, Dahl O Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy Acta Oncol. 2009;48(6):874-81

14. Kopek N, Holt MI, Hansen AT, Høyer M Stereotactic body radiotherapy for unresectable cholangiocarcinoma Radiother Oncol. 2010 Jan;94(1):47-52

13. Andersen CE, Nielsen SK, Lindegaard JC, Tanderup K Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy Med Phys. 2009 Nov;36(11):5033-43

12. Wright P, Redpath AT, Høyer M, Muren LP A method to individualize adaptive planning target volumes for deformable targets Phys Med Biol. 2009 Dec 7;54(23):7121-7133.

11. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J; HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol. 2010 Jan;94(1):30-5

10. Overgaard J. Chemoradiotherapy of head and neck cancer – Can the bumble bee fly? Radiother Oncol. 2009 Jul;92(1):1-3.

9. Kopek N, Paludan M, Petersen J, Hansen AT, Grau C, Høyer M. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol. 2009 Dec;93(3):402-7

8. Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van der Kogel A, Overgaard J. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol. 2009 Sep;92(3):429-36.

7. Andreassen CN, Alsner J Genetic variants and normal tissue toxicity after radiotherapy: A systematic review Radiother Oncol. 2009 Sep;92(3):299-309.

6. Sørensen BS, Horsman MR, Vorum H, Honoré B, Overgaard J, Alsner J Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics Radiother Oncol. 2009 Sep;92(3):443-9

5. Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer Radiother Oncol. 2009 May;91(2):187-93.

4. Offersen BV, Overgaard M, Kroman N, Overgaard J Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review Radiother Oncol. 2009 Jan;90(1):1-13.

3. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol. 2009 Apr 20;27(12):1992-8.

2. Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncol. 2009;48(2):238-44.

1. Andersen CE, Nielsen SK, Greilich S, Helt-Hansen J, Lindegaard JC, Tanderup K Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy Med Phys. 2009 Mar;36(3):708-18.